A critical discovery in cancer investigation is emerging with the use of nanobodies to re-engage mutated p53. This crucial cancer inhibitor protein is frequently disabled in various kinds of malignancies, resulting https://bookmarkzap.com/story21830374/vhh-fragments-restore-p53-new-new-hope-for-malignant-management